Source file signed link, expires in 15 minutes
Extracted text 27
Page 1
PUBLIC EXPOSE
PT KEDOYA ADYARAYA TBK
Jakarta, 25 March 2026
Page 2
Disclaimer
This presentation has been prepared by PT Kedoya Adyaraya Tbk (“RSGK”) as a general overview of the Company’s condition
and performance. The information contained herein does not constitute investment advice, an offer to buy or sell securities, or
any financial recommendation. It does not take into account the specific objectives, financial situation, or needs of any
particular party.
This presentation may contain forward-looking statements that reflect management’s current expectations regarding future
events, business performance, and financial conditions. These statements involve risks and uncertainties that may cause actual
results to differ materially from those expressed or implied. Past performance is not necessarily indicative of future results, and
RSGK undertakes no obligation to update any forward-looking statements.
The consolidated financial information presented, including the financial position as of 31 December 2025, has been prepared
in accordance with Indonesian Financial Accounting Standards (PSAK) and has been audited by an independent auditor.
While reasonable care has been taken in preparing this presentation, RSGK make no representation or warranty, express or
implied, as to the accuracy or completeness of the information contained herein and accept no liability for any loss arising from
reliance on this presentation.
150789 021 2977 9977 www.grhakedoya.com 2
Page 3
01 02 03
Company Strategic Financial
Overview Initiatives Performance
Review
Page 4
Company Overview
Page 5
Milestones
• Rebranding EMC Grha Kedoya
Hospital
• 2nd JCI Accreditation • Signing MOU with Siemens
• Rebranding EMC Healthineers for Biograph
Grand Opening Grha Kedoya Cibitung Hospital Vision Quadra PET/CT
Grha Kedoya Hospital Hospital has JCI accreditation
2011 2019 2022 2024
1990 2018 2021 2023 2025
Company Establishment IPO of PT Kedoya • Grand Launching Lexo & • Grand Launching Biograph
MM2100 Hospital Adyaraya Tbk Diego Vision Quadra PET/CT
Acquicition • TrakCare Intersystem • EMRAM Stage 6
Implementation • 3rd JCI Accreditation
• Transforming into an AI-
powered hospital group,
supported by the
implementation of
InterSystems IntelliCare and
a fully integrated Hospital
Information System (HIS)
across all units
150789 021 2977 9977 www.grhakedoya.com 5
Page 6
Board of Commissioners
JUSUP HALIMI dr. LIEM KIAN HONG HUNGKANG SUTEDJA MURNIADI CHANDRA dr. YANTO SANDY TJANG
President Commissioner Vice President Commissioner Commissioner Independent Commissioner Independent Commissioner
150789 021 2977 9977 www.grhakedoya.com 6
Page 7
Board of Directors
dr. JUNIWATI GUNAWAN HENDRA MUNANTO ARMEN ANTONIUS DJAN drg. NAILUFAR
President Director Director Director Director
150789 021 2977 9977 www.grhakedoya.com 7
Page 8
VISION
EMC aspires to provide the most trusted and
accessible healthcare for the advancement of the
nation's healthcare quality.
MISION
• Putting patients' needs and safety as our utmost priority
• Promoting culture of continuous learning and innovation
• Building healthcare centers of excellence
with international standard quality
VALUES
Empathy Meaningful Competence
& & &
Integrity Respect Innovation
8
Page 9
Group Structure & Shareholders
13,13% 77,31% 7,55%
99,00% 99,66% 99,50%
99,00%
Note : As of 13 March 2026 the Company’s Free Float shares
amount to 70,160,846 shares or representing 7.55% of
the total registered shares. The Company has comply
with provision V.1.1 IDX Regulation Number I-A
150789 021 2977 9977 www.grhakedoya.com 9
Page 10
Operational Area 150789 021 2977 9977 www.grhakedoya.com 10
Page 11
Profile of the Hospitals
Bed Operating theatre
Bed Operating theatre
200 4 120 4
Specialist Doctor Medical Staff
Specialist Doctor Medical Staff
128 368 40 167
150789 021 2977 9977 www.grhakedoya.com 11
Page 12
Awards & Certificates
(1) (2) (3) (4) (5)
(1) KARS Accreditation Certificate No. KARS- (4) Global Health Award for Advanced PET/CT
SERT/103/IX/2022 year 2022-2026 – EMC Cibitung Hospital (5) Validation of Electronic Medical Record Adoption Model
(2) KARS Accreditation Certificate No. KARSSERT/1487/VII/ (EMRAM) Stage 6, HIMSS, year 2025-2028
2024 year 2024-2028 – EMC Grha Kedoya Hospital
(3) JCI Accreditation, year 2025-2028
150789 021 2977 9977 www.grhakedoya.com 12
Page 13
Strategic Initiatives
Page 14
EMC
Healthcare
Strategic
Development
Plan
150789 021 2977 9977 www.grhakedoya.com 14
Page 15
Strategic Development Plan 150789 021 2977 9977 www.grhakedoya.com 15
Page 16
Biograph Vision Quadra PET/CT Scanner
at EMC Grha Kedoya Hospital
Latest Technology & First in Asia:
Using Biograph Vision Quadra, a leading-edge true
whole-body PET/CT scan that sets a new standard in
cancer diagnostics.
Ultra-Fast Scan Time:
A full-body (head-to-toe) scan takes only about 4
minutes, increasing patient comfort and reducing
anxiety.
High Resolution and Sensitivity:
Capable of detecting cancer cells or very small
abnormalities at the molecular level, even before
they are visible on conventional CT or MRI scans.
Lower Radiation:
The radiation dose is 50% to 75% lower than
standard PET/CT technology, making it safer for
patients, including for long-term monitoring or
pediatric patients.
106 cm Scanning Area:
The axial field of view reaches 106 cm, enabling
scanning of a large body area in a single session.
150789 021 2977 9977 www.grhakedoya.com 16
Page 17
AI Innovation and Patient’s Portal
Transition to a Fully AI-Driven Hospital Network
150789 021 2977 9977 www.grhakedoya.com 17
Page 18
Peningkatan Keamanan Data
HIS (Intellicare)
13
150789 021 2977 9977 www.grhakedoya.com 18
Page 19
Data Security Enhancement 150789 021 2977 9977 www.grhakedoya.com 19
Page 20
Collaborations and Strategic Initiatives 150789 021 2977 9977 www.grhakedoya.com 20
Page 21
Collaborations and Strategic Initiatives 150789 021 2977 9977 www.grhakedoya.com 21
Page 22
CSR Program 2025 150789 021 2977 9977 www.grhakedoya.com 22
Page 23
Financial Performance Review
Page 24
Statement of Profit or Loss
CONSOLIDATED STATEMENT OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 DECEMBER 2025 AND 31 DECEMBER 2024
Year Ending on Date Increase
Information
2025 2024 (Decrease)
Revenues 469,592,692,612 441,072,473,575 6%
Cost of Revenues (321,943,527,923) (291,749,619,707) 10%
Gross Profit 147,649,164,689 149,322,853,868 -1%
Operating Expenses (103,623,384,809) (97,735,863,928) 6%
Other Income - net 3,443,228,705 3,438,709,855 0%
Operating Income 47,469,008,585 55,025,699,795 -14%
Finance income 5,021,372,545 4,029,482,807 25%
Finance costs and Bank administration (7,250,660,746) (2,346,862,454) 209%
Profit before income tax 45,239,720,384 56,708,320,148 -20%
Income tax expenses - net (10,773,400,741) (17,110,463,907) -37%
Profit for the year 34,466,319,643 39,597,856,241 -13%
Other comprehensive income (3,343,352,721) 17,838,297,170 -119%
Total other comprehensive income for the year 31,122,966,922 57,436,153,411 -46%
Profit for the year attributable to:
Owners of the parent entity 34,507,058,537 39,692,367,036 -13%
Non-controlling interest (40,738,894) (94,510,795) -57%
150789 021 2977 9977 www.grhakedoya.com 24
Page 25
Statement of Financial Position
CONSOLIDATED STATEMENT OF FINANCIAL POSITION
AS OF 31 DECEMBER 2025 AND 31 DECEMBER 2024
31 December 31 December Increase
Information
2025 2024 (Decrease)
Assets
Total Current Asset 127,217,813,363 127,236,246,527 0%
Non-Current Assets 956,294,891,815 760,391,336,488 26%
Total Assets 1,083,512,705,178 887,627,583,015 22%
Liabilities
Non-current Liabilities 126,984,370,099 69,654,225,302 82%
Total Non-current Liabilities 126,759,253,678 19,512,451,817 550%
Total Liabilities 253,743,623,777 89,166,677,119 185%
Equity
Equity attributable to
owners of the parent entity 828,793,492,478 797,669,220,072 4%
Non-controlling interest 975,588,923 791,685,824 23%
Total Equity 829,769,081,401 798,460,905,896 4%
150789 021 2977 9977 www.grhakedoya.com 25
Page 26
Statement of Cash Flows
CONSOLIDATED STATEMENT OF CASH FLOWS
FOR THE YEAR ENDED 31 DECEMBER 2025 AND 31 DECEMBER 2024
31 Decmber 31 December Increase
Information
2025 2024 (Decrease)
Cash flows from operating activities 90,246,003,649 81,804,569,371 10%
Cash flows from investing activities (90,240,253,768) (74,604,778,093) 21%
Cash flows from financing activities 6,956,797,596 (10,226,425,000) 168%
Net increase/(decrease) in cash on hand and in Banks 6,962,547,477 (3,026,633,722) 330%
Cash on hand and in Banks at beginning of year 54,397,160,838 57,423,794,560 -5%
Cash on hand and in Banks at end of year 61,359,708,315 54,397,160,838 13%
150789 021 2977 9977 www.grhakedoya.com 26
Page 27
Names mentioned 13 people and organisations named in the text · linked when the evidence is strong
unresolved
org
PT Kedoya
p.5
unresolved
org
Adyaraya Tbk
p.5
unresolved
person
Vice
· President Commissioner
p.6 ×2
Extraction attempts how the parser did, and what it refused
Nothing structured was extracted from this document — the attempts below say why.
No extraction attempted yet.